|
|
|
|

|
October 8 ,
2009 | ISSUE NUMBER 119 VOL 6 |
Forecast
Global Pharma Market Growth to Grow 4 to 6 Percent in 2010
Sure, industry growth is at “historically low levels,” but at least pharma is still growing. The industry’s market value should surpass $825 billion in 2010, and forecasted growth was bumped up one percentage point from original estimates.
Vaccines
H1N1 Vaccine Hits the Market
Pulling off an incredibly fast turnaround, the pharma industry has released a vaccine for the H1N1 virus, bolstering its bottom line with a second flu vaccine and potentially helping millions of people. So why is there such an uproar over whether it’s safe?
Awards
Prix Galien: And the Winners Are…
The science elite gathered last week for an evening of celebration and reflection at the annual Prix Galien USA awards ceremony. It’s called the Nobel Prize of the science industry, and judging by the number of prestigious attendees, the moniker is justified.
Web Exclusive
The Changing Pharmaceutical Sales Landscape
Sales forces can achieve compliance and excellence through individual behavioral fine-tuning and company-wide cultural adjustment.
New & Noteworthy
A Different World: Q&A with Brent Saunders, Schering-Plough
Brent Saunders, Schering-Plough's president of global consumer healthcare, talks growing role of OTC drugs in Pharma's future. |
 |
 |
Novo Nordisk promoted Joan Schmidt to corporate vice president of legal affairs // Nile Therapeutics appointed Arie S. Belldegrun, M.D., to its board of directors
// Nancy Lynn was appointed executive vice president of the Alzheimer's Drug Discovery Foundation
// Saatchi & Saatchi Healthcare Innovations hired Annemarie Armstrong as executive vice president, director of account leadership
// Sinobiopharma appointed Xinjie (James) Mu as chief financial officer and as a director on the board
// AbelsonTaylor promoted Jeff Berg and Laura Bartmess to vice president, account director
// WCG hired Chris Black, director of digital strategy; and Liesel Enke, Geoff Knox, and Lauran Driver, associate
// Health Strategies Group launched Oncology Performance Edge, a new research service that helps marketing and sales executives in the oncology field improve brand performance
// EvoLogue hired Robert Velasco account group supervisor; Andrew Dalsass as a group art supervisor; Patty O’Brien as group copy supervisor; Scott Brown as senior copywriter; Heather Canova as a senior art director; and Maria Colicchio and Alison Fehn as account executive
// Raptor Pharmaceutical appointed Llew Keltner, M.D., to its board of directors
//Cornerstone Pharmaceuticals added Robert A. Weinberg to its scientific advisory board
// |
Advertisement:
"With [ACQUITY UPLC] we got some phenomenal results which we could just not do with HPLC…For us, it was a logical solution that we had to look then to putting UPLC on the front end of our mass spec systems. It would increase our throughput, up our instrument utilization, and make much more efficient use of the equipment that we have."
See success stories from laboratory-dependent organizations like yours
|
October 20 Applying E-Commerce Tools to Support Discovery and Development of Medicines: Key Lessons and Learnings
Tuesday, October 20, 2009 at 11AM ET
October 28 Disclosure of Drug Promotion Expenses: How Automated Reporting and Master Data Management Can Improve Compliance and Lower Costs
Wednesday, October 28, 2009 at 11AM EDT
December 2 Risk, Reward and the Pharmaceutical Life Cycle: Managing Information as a Strategic Productivity Asset
Wednesday, December 2, 2009 at 11AM ET
|
Oct 20–21 CBI’s Leadership Summit on Global Interactions with Healthcare Providers, Arlington, VA
Nov 9–10 Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders,
Princeton, NJ
Dec 8–9 Forum on FDA’s Structured Product Labeling, Washington, DC
|
|
|
|
 |
|
 |
 |
 |
This strategy of proactive engagement with non-traditional constituencies will succeed and preserve the industry business model and operating profits in the vital US market. |
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|